The Board of Fusion Micro Finance at its meeting held on 28 November 2022 has approved the proposal to raise funds by issue of Non-Convertible Debentures aggregating up to Rs 145 crore on private placement basis
Genomic Valley Biotech announced that the 28th Annual General Meeting AGM of the company will be held on 30 December 2022
Aditya Birla Sun Life AMC ABSLAMC has been granted approval by IFSCA on 28 November 2022 to act as Registered Fund Management Entity NonRetail and carry out Alternative Investment Fund AIF and Portfolio Management Services PMS through a branch office in International Financial Services Centre IFSC in India ABSLAMCs move to set up a new unit at the Gujarat International Finance Tec-City GIFT City is […]
Satin Creditcare Network will hold a meeting of the Board of Directors of the Company on 1 December 2022
Jenburkt Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1 December 2022
Lupin announced the launch of Formoterol Fumarate Inhalation Solution 20 mcg2 mL per Unit-Dose Vial to market a generic equivalent of Perforomist Inhalation Solution 20 mcg2 mL of Mylan Specialty LP Formoterol Fumarate Inhalation Solution RLD Perforomist had estimated annual sales of USD 268 million in the US IQVIA MAT September 2022
Suumaya Corp will hold a meeting of the Board of Directors of the Company on 2 December 2022
Vaishali Pharma will hold a meeting of the Board of Directors of the Company on 5 December 2022
Gland Pharma announced that it has through its wholly owned subsidiary Gland Pharma International Singapore entered into a Put Option Agreement to acquire 100Percentage of Cenexi Group for an Equity Value not exceeding Euro 120 Mn Enterprise Value of Euro 230 Mn Founded in 2004 Cenexi along with its Subsidiaries is engaged primarily in the business of Contract Development Manufacturing Organisation CDMO of pharmaceutical products […]
Tamilnad Mercantile Bank launched the marketing of Life Insurance Products and General Insurance products under the tie-up arrangement with Max Life Insurance Company and Cholamandalam MS General Insurance Company respectively

IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.